ReShape Lifesciences Inc. , a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
Reshape Lifesciences stock last closed at $0.38, up 23.55% from the previous day, and has decreased 96.04% in one year. It has underperformed other stocks in the Medical Devices industry by 0.77 percentage points. Reshape Lifesciences stock is currently +27.67% from its 52-week low of $0.30, and -98.68% from its 52-week high of $29.00.
As of Apr 21, 2025, there are 11.28M shares of RSLS outstanding. The market value of RSLS is $4.32M. In the past 24 hours, 150.42M RSLS shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy RSLS stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you are able to buy RSLS today.
Now that you have finished signing up on the best stock market app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help depositing funds into your new brokerage account.
Once you have identified the best place to buy Reshape Lifesciences stock, it's absolutely critical to research their stock before you invest, so you can understand the risk as well as the upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on RSLS's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge RSLS's intrinsic value.
You can do additional valuation research on RSLS's stock here.
Last year, RSLS revenue was $8.01M. During the last five year, RSLS's revenue has gone up by 19.53% per year. This was faster than the Medical Devices industry average of 9.8%.
You can analyze RSLS's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at RSLS have sold more shares than they have bought.
Thomas Stankovich, Chief Financial Officer of RSLS, was the latest RSLS insider to sell. They sold $12.00 worth of RSLS shares on May 31, 2024.
Dig into more about who owns RSLS stock here.
No, Reshape Lifesciences doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two primary options:
Press the Open button and your broker will place your order.
If you require more assistance buying stocks on eToro, watch the helpful video below:
Now that you own some RSLS stock, you'll want to stay up-to-date on your new stock purchase.
Put RSLS on a watchlist to monitor your RSLS stock.
To summarize, here are the 6 steps for buying Reshape Lifesciences stock:
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Reshape Lifesciences, add RSLS to your watchlist by clicking the button below.